Jian Xiong

Jian Xiong

Central US Merck & Co., Inc. - Kenilworth / United States
Others
AD Scientific Index ID: 5415253
-
person_outline Jian Xiong's MOST POPULAR ARTICLES
1-) Development of spirulina for the manufacture and oral delivery of protein therapeuticsBW Jester, H Zhao, M Gewe, T Adame, L Perruzza, DT Bolick, J Agosti, ...Nature biotechnology 40 (6), 956-964, 2022692022
2-) A formulation development approach to identify and select stable ultra–high-concentration monoclonal antibody formulations with reduced viscositiesN Whitaker, J Xiong, SE Pace, V Kumar, CR Middaugh, SB Joshi, ...Journal of pharmaceutical sciences 106 (11), 3230-3241, 2017692017
3-) Preformulation characterization and stability assessments of secretory IgA monoclonal antibodies as potential candidates for passive immunization by oral administrationY Hu, OS Kumru, J Xiong, LR Antunez, J Hickey, Y Wang, L Cavacini, ...Journal of Pharmaceutical Sciences 109 (1), 407-421, 2020262020
4-) Developability assessment of physicochemical properties and stability profiles of HIV-1 BG505 SOSIP. 664 and BG505 SOSIP. v4. 1-GT1. 1 gp140 envelope glycoprotein trimers as …N Whitaker, JM Hickey, K Kaur, J Xiong, N Sawant, A Cupo, WH Lee, ...Journal of pharmaceutical sciences 108 (7), 2264-2277, 2019252019
5-) Simultaneous Observation of Peptide Backbone Lipid Solvation and α‐Helical Structure by Deep‐UV Resonance Raman SpectroscopyCM Halsey, J Xiong, OO Oshokoya, JA Johnson, S Shinde, JT Beatty, ...ChemBioChem 12 (14), 2125-2128, 2011242011